Phase 1 multicenter, open label, dose-escalation study of LEE011, an oral inhibitor of cyclin-dependent kinase 4/6, in patients with advanced solid tumors or lymphomas
Year: 2013
Type: article
Study design: Clinical Trial
Authors: infante, J, gerecitano, G, Chugh , r, cassier , P, ribrag, V, shapiro, G, witteveen, E, Matano, Alessandro, Chakraborty, Abhijit, Parasuraman, Sudha
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7042665903
